Show simple item record

dc.contributor.authorKim, J-H
dc.contributor.authorKurtz, A
dc.contributor.authorYuan, B-Z
dc.contributor.authorZeng, F
dc.contributor.authorLomax, G
dc.contributor.authorLoring, JF
dc.contributor.authorCrook, J
dc.contributor.authorJu, JH
dc.contributor.authorClarke, L
dc.contributor.authorInamdar, MS
dc.contributor.authorPera, M
dc.contributor.authorFirpo, MT
dc.contributor.authorSheldon, M
dc.contributor.authorRahman, N
dc.contributor.authorO'Shea, O
dc.contributor.authorPranke, P
dc.contributor.authorZhou, Q
dc.contributor.authorIsasi, R
dc.contributor.authorRungsiwiwut, R
dc.contributor.authorKawamata, S
dc.contributor.authorOh, S
dc.contributor.authorLudwig, T
dc.contributor.authorMasui, T
dc.contributor.authorNovak, TJ
dc.contributor.authorTakahashi, T
dc.contributor.authorFujibuchi, W
dc.contributor.authorKoo, SK
dc.contributor.authorStacey, GN
dc.date.accessioned2020-12-21T03:52:35Z
dc.date.available2020-12-21T03:52:35Z
dc.date.issued2017-11-01
dc.identifier.citationKim, J. -H., Kurtz, A., Yuan, B. -Z., Zeng, F., Lomax, G., Loring, J. F., Crook, J., Ju, J. H., Clarke, L., Inamdar, M. S., Pera, M., Firpo, M. T., Sheldon, M., Rahman, N., O'Shea, O., Pranke, P., Zhou, Q., Isasi, R., Rungsiwiwut, R. ,... Stacey, G. N. (2017). Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. STEM CELLS TRANSLATIONAL MEDICINE, 6 (11), pp.1956-1962. https://doi.org/10.1002/sctm.17-0144.
dc.identifier.issn2157-6564
dc.identifier.urihttp://hdl.handle.net/11343/257391
dc.description.abstractThis article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19-20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956-1962.
dc.languageEnglish
dc.publisherWILEY
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.titleReport of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells
dc.typeJournal Article
dc.identifier.doi10.1002/sctm.17-0144
melbourne.affiliation.departmentSurgery (St Vincent's)
melbourne.affiliation.departmentAnatomy and Neuroscience
melbourne.source.titleStem Cells Translational Medicine
melbourne.source.volume6
melbourne.source.issue11
melbourne.source.pages1956-1962
dc.rights.licenseCC BY-NC-ND
melbourne.elementsid1270526
melbourne.contributor.authorPera, Martin
melbourne.contributor.authorCrook, Jeremy
dc.identifier.eissn2157-6580
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record